Related content

Conversations with Mike Milken

Moonshot, with Johnson & Johnson’s Alex Gorsky

That’s Johnson & Johnson CEO Alex Gorsky talking about the $1 billion partnership his company formed with BARDA, the U.S. Biomedical Advanced Research and Development Authority. The company is ramping up so that if the accelerated clinical trials are successful, J&J will be prepared to produce and ship by early 2021.


For a limited time: Become a Charter Member!